Colleen M Kane

US Patent:

20110318353, Dec 29, 2011

Filed:

Mar 30, 2011

Appl. No.:

13/075241

Inventors:

Juan Carlos Almagro - Radnor PA, US
Patrick Branigan - Radnor PA, US
Colleen Kane - Radnor PA, US
William Strohl - Radnor PA, US
Susann Taudte - Radnor PA, US
Mark Tornetta - Radnor PA, US
John Wheeler - Radnor PA, US

International Classification:

A61K 39/395
C12N 15/13
C12N 15/63
A61P 29/00
C12N 1/21
C12P 21/00
C12P 21/02
A61P 11/06
C07K 16/24
C12N 5/10

US Classification:

4241391, 5303879, 5303892, 536 2353, 4353201, 435331, 435335, 4352523, 43525233, 435 696, 4241581, 5303873

Abstract:

The present invention relates to target binding members (e.g., antibodies) that bind a specified epitope of human IL-25. The invention also relates to target binding members (e.g., antibodies) that comprise one or more humanized antibody VL domain sequences and bind IL-25. The invention further relates to compositions comprising target binding members (e.g., antibodies) that bind IL-25, methods of producing such target binding members, and uses of such target binding members for the treatment or prevention of diseases and conditions (e.g., asthma, inflammatory bowel disease).

US Patent:

20220411504, Dec 29, 2022

Filed:

May 26, 2021

Appl. No.:

17/330462

Inventors:

- Horsham PA, US
Scott R. Brodeur - New Hope PA, US
Rajkumar Ganesan - Blue Bell PA, US
Jaclyn Hoover - Conshohocken PA, US
Steven A. Jacobs - North Wales PA, US
Colleen M. Kane - Flourtown PA, US
Jinquan Luo - Malvern PA, US
Sanjaya Singh - Blue Bell PA, US
Fang Yi - Collegeville PA, US
Adam Zwolak - Bala Cynwyd PA, US
Triveni K. Bhatt - Perkasie PA, US
Michael Dennis Feldkamp - Blue Bell PA, US
Sherry Lynn La Porte - Horsham PA, US

International Classification:

C07K 16/28
A61P 35/00
C07K 16/30
C07K 16/42

Abstract:

The disclosure provides antigen binding domains that bind cluster of differentiation 3 (CD3) protein, comprising the antigen binding domains that bind CD3ε, polynucleotides encoding them, vectors, host cells, methods of making and using them.

US Patent:

20230040715, Feb 9, 2023

Filed:

Mar 23, 2022

Appl. No.:

17/701764

Inventors:

- Horsham PA, US
Raymond Brittingham - Blue Bell PA, US
Scott R. Brodeur - New Hope PA, US
Rajkumar Ganesan - Thousand Oaks CA, US
Sherry Lynn La Porte - Horsham PA, US
Jinquan Luo - Malvern PA, US
Fang Yi - Collegeville PA, US
Colleen M. Kane - Flourtown PA, US
Triveni K. Bhatt - Perkasie PA, US

International Classification:

C07K 16/28
C07K 16/46
C12N 15/85

Abstract:

The disclosure provides antigen binding domains that bind cluster of differentiation 3 (CD3) protein, comprising the antigen binding domains that bind CD3ε, polynucleotides encoding them, vectors, host cells, methods of making and using them.

US Patent:

20200024360, Jan 23, 2020

Filed:

May 21, 2019

Appl. No.:

16/418328

Inventors:

- Horsham PA, US
Tammy Bush - Perkasie PA, US
Rosa Maria Fernandes Cardoso - Berwyn PA, US
Ellen Chi - Del Mar CA, US
Judith Ann Connor - Vista CA, US
Thai Quang Dinh - Solana Beach CA, US
Derrick Lemon Domingo - Carlsbad CA, US
John Michael Jones - Ambler PA, US
Colleen Kane - Flourtown PA, US
Bethany Kay Mattson - Conoshohocken PA, US
Theresa Marie McDevitt - Warminster PA, US
Jill Marie Mooney - San Diego CA, US
Richard Stephen Tawadros - Norristown PA, US
Hong Mimi Zhou - San Diego CA, US

International Classification:

C07K 16/30
C07K 16/28

Abstract:

The present invention relates to antibodies specifically binding PSMA or PSMA and CD3, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.

US Patent:

20190359711, Nov 28, 2019

Filed:

May 21, 2019

Appl. No.:

16/417889

Inventors:

- Horsham PA, US
Robin Ernst - Kintnersville PA, US
Rajkumar Ganesan - Blue Bell PA, US
Colleen Kane - Flourtown PA, US
Michael Russell - West Chester PA, US
Sanjaya Singh - Blue Bell PA, US
Sathyadevi Venkataramani - Blue Bell PA, US
Sheng-Jiun Wu - Broomall PA, US

Assignee:

Janssen Biotech, Inc. - Horsham PA

International Classification:

C07K 16/28
A61P 35/00

Abstract:

The disclosure provided herein relates to monospecific and multispecific anti-TMEFF2 antibodies, and methods of producing and using the described antibodies.